~~<i id='3174294E16'><strike id='3174294E16'><tt id='3174294E16'><pre id='3174294E16'></pre></tt></strike></i>~~

Home» knowledge» explore

explore

author：focus 2025-09-29 07:23:22 Page View：718

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： A new study sees potential in DNA sequencing of infants
Next article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

leisure time

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

2:07E.JeanCarrollwalksoutofManhattanfederalcourt,May9,2023,inNewYork.JohnMinchillo/AP,FILETheJustice

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

ThisphotoreleasedbyTelegramChannelofRostov-on-DonRegionGovernorVasiliyGolubevshowsthesiteofanexplosi